SAB Biotherapeutics, Inc. (SABS): 8-K filed Apr 22, 2026

Form type

8-K

Filing date

Apr 22, 2026

Accession number

0001193125-26-168569

Filer

SAB Biotherapeutics, Inc. (CIK 1833214)